FDA Approves Once-Weekly Bydureon BCise (exenatide) for Patients with Type-2 Diabetes

Article Link: FDA Approves Once-Weekly Bydureon BCise (exenatide) for Patients with Type-2 Diabetes



Source: FDA New Drug Approvals